211
Views
6
CrossRef citations to date
0
Altmetric
Oncology: Original Article

Effectiveness of adjuvant imatinib in patients with gastrointestinal stromal tumor: results of a population-based, matched-cohort study

, , &
Pages 805-814 | Accepted 02 Apr 2012, Published online: 30 Apr 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Annie Guerin, Medha Sasane, Genevieve Gauthier, Christopher H. Keir, Maryia Zhdavana & Eric Q. Wu. (2015) The economic burden of gastrointestinal stromal tumor (GIST) recurrence in patients who have received adjuvant imatinib therapy. Journal of Medical Economics 18:3, pages 241-248.
Read now

Articles from other publishers (5)

Michael Stokes, Carolina Reyes, Yu Xia, Veronica Alas, Hans-Peter Goertz & Luke Boulanger. (2017) Impact of pharmacy channel on adherence to oral oncolytics. BMC Health Services Research 17:1.
Crossref
Katherine A. Lyseng-Williamson. (2014) Imatinib: a guide to its use as adjuvant therapy for gastrointestinal stromal tumour (GIST) in the EU. Drugs & Therapy Perspectives 31:2, pages 45-51.
Crossref
Monica P. Davey. (2014) Mejorar la adherencia al tratamiento antineoplásico oral. Nursing (Ed. española) 31:3, pages 53-57.
Crossref
Monica P. Davey. (2013) Improving adherence to oral anticancer therapy. Nursing 43:9, pages 31-36.
Crossref
Eusebio Contreras, Haroldo Estrada & Estebana Benedetti. (2013) Tumores estromales gastrointestinales en el Hospital Universitario del Caribe, Cartagena de Indias, Colombia, 2009–2011. Serie de casos. Revista Colombiana de Cancerología 17:1, pages 33-39.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.